Sarah Gheuens
Chief Medical Officer · 3 filings · Latest: Jun 18, 2026
AGIOS PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AGIO | Gheuens Sarah | — | Jul 1, 2026 | Proposed Sale | $37.56 | 4,007 | $150.5K | — | |
AGIO | Sarah Gheuens | Chief Medical Officer | Apr 2, 2026 | Sale | $34.71 | 2,940 | $102.0K | 80,277 | |
AGIO | Sarah Gheuens | Chief Medical Officer | Apr 2, 2026 | Option Exercise | $0.00 | 8,500 | — | 83,217 | |
AGIO | Gheuens Sarah | — | Apr 2, 2026 | Proposed Sale | $34.19 | 2,940 | $100.5K | — | |
AGIO | Sarah Gheuens | Chief Medical Officer | Mar 2, 2026 | Sale | $28.96 | 4,055 | $117.4K | 74,406 | |
AGIO | Sarah Gheuens | Chief Medical Officer | Mar 2, 2026 | Option Exercise | $0.00 | 13,666 | — | 75,593 | |
AGIO | Gheuens Sarah | — | Mar 2, 2026 | Proposed Sale | $30.23 | 4,055 | $122.6K | — | |
AGIO | Gheuens Sarah | — | Dec 30, 2025 | Proposed Sale | $27.16 | 2,932 | $79.6K | — | |
AGIO | SARAH GHEUENS | — | Nov 11, 2025 | Proposed Sale | $43.78 | 2,454 | $107.4K | — | |
AGIO | SARAH GHEUENS | — | Oct 30, 2025 | Proposed Sale | $43.81 | 200 | $8.8K | — | |
AGIO | SARAH GHEUENS | — | Oct 27, 2025 | Proposed Sale | $43.92 | 3,302 | $145.0K | — | |
AGIO | SARAH GHEUENS | — | Jul 9, 2025 | Proposed Sale | $37.99 | 11,914 | $452.6K | — | |
AGIO | Gheuens Sarah | — | Jul 1, 2025 | Proposed Sale | $34.37 | 4,091 | $140.6K | — | |
AGIO | Gheuens Sarah | — | Jun 24, 2025 | Proposed Sale | $34.41 | 1,761 | $60.6K | — | |
AGIO | Gheuens Sarah | — | Mar 3, 2025 | Proposed Sale | $35.54 | 4,005 | $142.3K | — |